Dr. Morrow is the first surgeon and the first person from Memorial Sloan-Kettering to receive the American Society of Clinical Oncology’s award, which recognizes breast cancer researchers who are also excellent mentors.

Breast Surgical Service Chief Monica Morrow provides perspective on assessing the quality of surgical breast cancer treatment in an editorial in the February 1 issue of the Journal of the American Medical Association.

Recent findings by Memorial Sloan-Kettering investigators suggest it might be possible to improve the effectiveness of chemotherapy for breast cancer by combining the treatment with a new type of drug called a cathepsin inhibitor.

Research published in the November 19 issue of The Lancet finds that MRI use for breast cancer screening in women at high risk for the disease – due to family history or a genetic mutation – detects more cancers than screening mammography.